Regeneron Pharmaceuticals Inc. sell Bank of America Co.
Start price
29.03.23
/
50%
€756.00
Target price
29.03.24
€599.43
Performance (%)
19.37%
End price
30.03.24
€902.40
Summary
This prediction ended on 30.03.24 with a price of €902.40. The SELL prediction by Bank_of_America_Co_ finished with a performance of 19.37%. Bank_of_America_Co_ has a follow-up prediction for Regeneron Pharmaceuticals Inc., but this time predicts that Regeneron Pharmaceuticals Inc. is a Buy. Bank_of_America_Co_ has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -2.342% | -2.342% | 13.774% | -25.007% |
| iShares Core DAX® | -2,80 % | -1,40 % | -0,22 % | 48,43 % |
| iShares Nasdaq 100 | -6,35 % | -0,41 % | 29,00 % | 84,28 % |
| iShares Nikkei 225® | -6,94 % | -0,28 % | 48,21 % | 59,28 % |
| iShares S&P 500 | -3,41 % | 0,40 % | 20,28 % | 62,51 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at Bank of America Co. from $605.00 to $650.00. They now have an "underperform" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€678.20
07.01.26
07.01.26
€734.96
07.01.27
07.01.27
-21.15%
16:19
16:19
Stopped prediction by Bank_of_America_Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€480.80
17.04.25
17.04.25
€481.36
17.04.26
17.04.26
31.22%
18.04.26
18.04.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€851.20
12.04.24
12.04.24
€676.58
12.04.25
12.04.25
-41.86%
13.04.25
13.04.25